APUS logo

Apimeds Pharmaceuticals US, Inc. Stock Price

NYSEAM:APUS Community·US$24.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

APUS Share Price Performance

US$0
-2.20 (-100.00%)
US$0
-2.20 (-100.00%)
Price US$0

APUS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Apimeds Pharmaceuticals US, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About APUS

Founded
n/a
Employees
n/a
CEO
Youngjik Cho
WebsiteView website
www.mindwavedao.com

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Recent APUS News & Updates

Recent updates

No updates